SCHEMBL29340025

SCHEMBL29340025

CCc1nn(Cc2ccc(OC)cc2)cc1C(O)c1nc(Br)cs1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AADAT Q8N5Z0 1/20 0.34
▸ PDE1B Q01064 2/20 0.33
▸ PDE1A P54750 1/20 0.33
▸ PDE1C Q14123 1/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ HDAC1 Q13547 2/20 0.32
▸ HSP90AA1 P07900 2/20 0.31
▸ HSP90AB1 P08238 1/20 0.31
▸ CACNA1G O43497 1/20 0.31
▸ CACNA1H O95180 1/20 0.31
▸ CACNA1I Q9P0X4 1/20 0.31
▸ ADORA3 P0DMS8 1/20 0.31
▸ KDM1A O60341 1/20 0.31
▸ HDAC2 Q92769 1/20 0.31
▸ HDAC8 Q9BY41 1/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31
▸ HDAC5 Q9UQL6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27163326 0.83 KDM4E (0.39) NPC1RAB9AHSP90AA1L3MBTL1
SCHEMBL29339884 0.79 KMT2A (0.37) AADATKMT2AMEN1NPC1RAB9A
SCHEMBL29339779 0.78 CYP1A2 (0.46) AADATPDE1BPDE1APDE1CKMT2A
SCHEMBL27816056 0.73 CACNA1H (0.41) AADATKMT2AMEN1NPC1RAB9A
SCHEMBL27163328 0.72 PTGER4 (0.39) NPC1RAB9AL3MBTL1
SCHEMBL27816057 0.71 KMT2A (0.39) AADATKMT2AMEN1NPC1RAB9A
SCHEMBL4552450 0.69 MEN1 (0.45) AADATKMT2AMEN1NPC1RAB9A
SCHEMBL29339707 0.68 MEN1 (0.44) AADATKMT2AMEN1NPC1RAB9A
SCHEMBL3359322 0.67 KMT2A (0.46) AADATKMT2AMEN1NPC1RAB9A
SCHEMBL370507 0.67 KMT2A (0.53) AADATKMT2AMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2024-07-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF UACA, ADCYAP1R1, ADCY1 AADAT 1363/4885PDE1B 79/4885PDE1A 104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback